Details for 2016778600
Up to date per 04.04.2026
Actions
Details for 2016778600
Granted/Registered
European Patent
01.08.2018 A
27.12.2023 B1
25.09.2015
US
201562233032 P
22.04.2016
US
201615136650
A61K 38/26 20060101AFI20170411BHEP
Owner
Xeris Pharmaceuticals, Inc.1375 West Fulton Street, Suite 1300 Chicago, IL 60607US
Representative
Representative
Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT
Inventor
PRESTRELSKI, Stevenc/o Xeris Pharmaceuticals, Inc. 3208 Red River Street Suite 300 Austin, TX 78705US
DONOVAN, Martinc/o Xeris Pharmaceuticals, Inc. 3208 Red River Street Suite 300 Austin, TX 78705US
SANDOVAL, Michaelc/o Xeris Pharmaceuticals, Inc. 3208 Red River Street Suite 300 Austin, TX 78705US
Information about Fees